Ralimetinib (LY2228820) dimesylate
Product Specifications
CAS Number
862507-23-1
Target
P38 MAPK
Applications
MAPK
Smiles
CC (C) (C) CN1C2=C (C=CC (=N2) C3=C (N=C (N3) C (C) (C) C) C4=CC=C (C=C4) F) N=C1N.CS (=O) (=O) O.CS (=O) (=O) O
Molecular Formula
C24H29FN6.2CH4O3S
Additionnal Information
Ralimetinib (LY2228820) dimesylate is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM in a cell-free assay, does not alter p38 MAPK activation. Phase 1/2.
Storage Conditions
2 years -80 in solvent
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470352-500 1x 500 µL
CD31 / PECAM-1 (158-2B3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881231-100 1x 100 µL
Eosinophil Peroxidase (AHE-1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040158-100 1x 100 µL
Cytokeratin 17 (E3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880147-500 1x 500 µL
Pgp9.5 (UCHL-1) (13C4), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details